UPDATE: Oppenheimer Reiterates Perform Rating, Raises PT on DexCom on 4Q12 Revenues
Posted on February 22, 2013 at 13:40 PM EST
In a report published Friday, Oppenheimer reiterated its Perform rating on DexCom (NASDAQ: DXCM ), and slightly raised its price target from $14.00 to $15.00. Oppenheimer noted, “DexCom's 4Q12 revenues of $33M included $31.7M in product revenues (in line with pre-announcement). Management reiterated 2013 product revenue guidance of $120-130M. The